Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Sainty

Showing results (41-50 of 120) with videos related to

Pageof 12
Sort By:
Leukemia|October 12, 1999
The immunophenotype of minimally differentiated acute myeloid leukemia (AML-M0): reduced immunogenicity and high frequency of CD34+/CD38- leukemic progenitorsR Costello, F Mallet, H Chambost, et al.
European Journal of Haematology|July 1, 1993
In vitro inhibition of interleukin-2-induced defective polymorphonuclear chemotaxis by TNF inhibitorC Fossat, D Sainty, A M Stoppa, et al.
Clinical and Laboratory Haematology|August 8, 2001
A standardized flow cytometric method for screening paroxysmal nocturnal haemoglobinuria (PNH) measuring CD55 and CD59 expression on erythrocytes and granulocytesU Oelschlaegel, I Besson, C Arnoulet, et al.
Leukemia|September 13, 2003
Myelodysplastic features developing in Philadephia-negative cells during imatinib mesylate therapy for CML: report of a new caseM J Mozziconacci, S Caillères, C Maurice, et al.
Leukemia|January 19, 2000
Acute myeloid leukaemia triggering via CD40 induces leukocyte chemoattraction and cytotoxicity against allogenic or autologous leukemic targetsR T Costello, F Mallet, H Chambost, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 1999
Acute myeloid leukemia and myelodysplasia in patients with chronic lymphocytic leukemia receiving fludarabine as initial therapyD Coso, R Costello, R Cohen-Valensi, et al.
Cancer Genetics and Cytogenetics|May 22, 1998
Askin tumor and acute myeloid leukemia in a patient with constitutional partial Y disomyM J Mozziconacci, H Sobol, R Costello, et al.
British Journal of Haematology|January 1, 1997
t(4;12)(q11;p13) in a CD7-negative acute myeloid leukaemiaD Sainty, C Arnoulet, M J Mozziconacci, et al.
Cancer Research|September 2, 2000
Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacitiesR T Costello, F Mallet, B Gaugler, et al.
Archives of Pathology & Laboratory Medicine|December 1, 1987
New parameters in erythrocyte counting. Value of histogramsC Fossat, M David, J R Harle, et al.
Pageof 12

Showing results (41-50 of 120) with videos related to

Sort By:
Pageof 12
Leukemia|October 12, 1999
The immunophenotype of minimally differentiated acute myeloid leukemia (AML-M0): reduced immunogenicity and high frequency of CD34+/CD38- leukemic progenitorsR Costello, F Mallet, H Chambost, et al.
European Journal of Haematology|July 1, 1993
In vitro inhibition of interleukin-2-induced defective polymorphonuclear chemotaxis by TNF inhibitorC Fossat, D Sainty, A M Stoppa, et al.
Clinical and Laboratory Haematology|August 8, 2001
A standardized flow cytometric method for screening paroxysmal nocturnal haemoglobinuria (PNH) measuring CD55 and CD59 expression on erythrocytes and granulocytesU Oelschlaegel, I Besson, C Arnoulet, et al.
Leukemia|September 13, 2003
Myelodysplastic features developing in Philadephia-negative cells during imatinib mesylate therapy for CML: report of a new caseM J Mozziconacci, S Caillères, C Maurice, et al.
Leukemia|January 19, 2000
Acute myeloid leukaemia triggering via CD40 induces leukocyte chemoattraction and cytotoxicity against allogenic or autologous leukemic targetsR T Costello, F Mallet, H Chambost, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 1999
Acute myeloid leukemia and myelodysplasia in patients with chronic lymphocytic leukemia receiving fludarabine as initial therapyD Coso, R Costello, R Cohen-Valensi, et al.
Cancer Genetics and Cytogenetics|May 22, 1998
Askin tumor and acute myeloid leukemia in a patient with constitutional partial Y disomyM J Mozziconacci, H Sobol, R Costello, et al.
British Journal of Haematology|January 1, 1997
t(4;12)(q11;p13) in a CD7-negative acute myeloid leukaemiaD Sainty, C Arnoulet, M J Mozziconacci, et al.
Cancer Research|September 2, 2000
Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacitiesR T Costello, F Mallet, B Gaugler, et al.
Archives of Pathology & Laboratory Medicine|December 1, 1987
New parameters in erythrocyte counting. Value of histogramsC Fossat, M David, J R Harle, et al.
Pageof 12